Scarica l'app Stockscreener
18.50
3.80%
-0.73
Dopo l'orario di chiusura:
18.52
0.02
+0.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Precedente Chiudi:
$19.23
Aprire:
$19.25
Volume 24 ore:
1.96M
Relative Volume:
0.87
Capitalizzazione di mercato:
$2.82B
Reddito:
$205.22M
Utile/perdita netta:
$-121.24M
Rapporto P/E:
-22.72
EPS:
-0.8141
Flusso di cassa netto:
$-82.81M
1 W Prestazione:
+5.29%
1M Prestazione:
+10.78%
6M Prestazione:
+74.36%
1 anno Prestazione:
+135.67%
Intervallo 1D:
$18.43
$19.34
Intervallo di 1 settimana:
$17.54
$19.42
Portata 52W:
$6.255
$20.76
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Nome
Adaptive Biotechnologies Corp
Settore
Industria
Telefono
206-659-0067
Indirizzo
1165 EASTLAKE AVE E, SEATTLE, WA
Confronta ADPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
18.50 | 2.94B | 205.22M | -121.24M | -82.81M | -0.8141 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.91 | 120.31B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.13 | 81.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
846.75 | 53.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
349.58 | 46.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
350.00 | 37.20B | 4.98B | 69.59M | 525.67M | 0.5197 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-09-30 | Iniziato | Guggenheim | Buy |
| 2025-06-18 | Iniziato | Craig Hallum | Buy |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-21 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Underperform |
| 2022-06-03 | Iniziato | Piper Sandler | Neutral |
| 2022-02-16 | Reiterato | BTIG Research | Buy |
| 2022-02-16 | Reiterato | BofA Securities | Buy |
| 2022-02-16 | Reiterato | Goldman | Neutral |
| 2022-02-16 | Reiterato | JP Morgan | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-03-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Iniziato | Goldman | Buy |
| 2019-07-23 | Iniziato | BTIG Research | Buy |
| 2019-07-22 | Iniziato | BofA/Merrill | Buy |
| 2019-07-22 | Iniziato | Cowen | Outperform |
| 2019-07-22 | Iniziato | Goldman | Neutral |
| 2019-07-22 | Iniziato | Guggenheim | Buy |
| 2019-07-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Biotech using immune genetics schedules Feb. and March investor webcasts - Stock Titan
The Analyst Verdict: Adaptive Biotechnologies In The Eyes Of 4 Experts - Benzinga
Guggenheim Raises Price Target for ADPT to $21, Maintains Buy Rating | ADPT Stock News - GuruFocus
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 - The Manila Times
Hear Adaptive Biotechnologies' 2025 results live on Feb. 5 - Stock Titan
First Week of March 20th Options Trading For Adaptive Biotechnologies (ADPT) - Nasdaq
Sumitomo Mitsui Trust Group Inc. Trims Holdings in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Aug Selloffs: Will Adaptive Biotechnologies Corporation stock go up in YEARJuly 2025 Spike Watch & Comprehensive Market Scan Insights - baoquankhu1.vn
Adaptive Biotechnologies Insider Sold Shares Worth $1,411,131, According to a Recent SEC Filing - marketscreener.com
Adaptive Biotechnologies’ Lo Francis sells $1.4m in shares By Investing.com - Investing.com South Africa
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells 79,590 Shares of Stock - MarketBeat
Adaptive Biotechnologies’ Lo Francis sells $1.4m in shares - Investing.com
Adaptive Biotechnologies CFO Piskel sells $77,220 in shares - Investing.com
Adaptive Biotechnologies Exec Sells Shares - TradingView — Track All Markets
Assessing Adaptive Biotechnologies (ADPT) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
Piper Sandler reiterates Overweight rating on Adeptus Biotechnologies stock By Investing.com - Investing.com Australia
What's Going On With Adaptive Biotechnologies Shares Tuesday? - Benzinga
Piper Sandler reiterates Overweight rating on Adeptus Biotechnologies stock - Investing.com
Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Revenue Growth Surges Over 100%, Analysts Eye 9.53% Upside - DirectorsTalk Interviews
Adaptive Biotechnologies Touts clonoSEQ MRD Growth, Targets Companywide Profitability in 2026 - Yahoo Finance
Adaptive Biotechnologies (ADPT) Surpasses Q4 Revenue Estimates, Shares Climb - GuruFocus
Adaptive Biotechnologies' Q4 Preliminary Revenue Rises 51%; Shares Jump in Premarket Trading - marketscreener.com
Adaptive Biotechnologies Rises 10% As Revenue Surges Over 50% - Nasdaq
Adaptive Biotechnologies reports 55% revenue growth in 2025 - Investing.com
Adaptive Biotechnologies reports 55% revenue growth in 2025 By Investing.com - Investing.com UK
Adaptive Biotechnologies announces preliminary fourth quarter and full year 2025 results - marketscreener.com
Adaptive Biotechnologies Reports Preliminary Financial Results for Q4 and Full Year 2025, Highlighting Significant Revenue Growth - Quiver Quantitative
Adaptive Biotechnologies stock soars after strong Q4 revenue beat - Investing.com
Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results - The Manila Times
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells $164,400.00 in Stock - Defense World
Adaptive Biotechnologies Corporation $ADPT Holdings Trimmed by Peregrine Capital Management LLC - MarketBeat
Adaptive Biotechnologies CSO Robins sells $164k in shares By Investing.com - Investing.com UK
Insider Sell: Harlan Robins Sells Shares of Adaptive Biotechnolo - GuruFocus
Adaptive Biotechnologies CSO Robins sells $164k in shares - Investing.com India
Meme Stocks: Will Adaptive Biotechnologies Corporation (1HM) stock profit from automation waveMarket Movers & Smart Money Movement Alerts - Улправда
Adaptive Biotechnologies assumed with an Equal Weight at Morgan Stanley - MSN
Adaptive Biotechnologies Insider Sold Shares Worth $1,948,719, According to a Recent SEC Filing - marketscreener.com
Adaptive Biotechnologies’ Lo Francis sells $76,895 in shares By Investing.com - Investing.com UK
Chad Robins Sells 124,998 Shares of Adaptive Biotechnologies Cor - GuruFocus
Adaptive Biotechnologies CEO Robins sells $1.95 million in shares - Investing.com
Adaptive Biotechnologies CEO Sells Over $1.9 Million in Company Stock - TradingView — Track All Markets
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 6.7%Time to Buy? - MarketBeat
Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale - TechStock²
Adaptive Biotechnologies CPO Lo sells $50k in ADPT stock By Investing.com - Investing.com UK
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Francis Lo Sells 3,125 Shares - MarketBeat
Adaptive Biotechnologies CPO Lo sells $50k in ADPT stock - Investing.com India
Adaptive Biotechnologies Corporation (ADPT) Stock Analysis: Unraveling Its 22.8% Potential Upside - DirectorsTalk Interviews
Adaptive Biotechnologies discloses it's raising $15 million for subsidiary - The Business Journals
Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Biotech company heads to major healthcare conference in San Francisco - Stock Titan
Adaptive Biotechnologies announces subsidiary’s Series A financing round By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies Corp Azioni (ADPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.49%
4.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):